Anti-Inflammatory Drugs Market Size, Share & Industry Analysis, By Drug Class (Anti-inflammatory Biologics, Non-steroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids), By Application (Autoimmune Inflammatory Diseases (Rheumatoid Arthritis Psoriasis), Respiratory Diseases), By Route of Administration (Oral, Injection, Inhalation, and Topical), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), and Regional Forecast, 2020-2032

Last Updated: February 10, 2025 | Format: PDF | Report ID: FBI102825

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
Key Insights
1. Prevalence of Major Diseases – For Key Countries
2. Pipeline Analysis
3. Patent Snapshot
4. New Product Launches
5. Key Industry Developments - Mergers, Acquisitions and Partnerships
Global Anti-inflammatory Drugs Market Analysis, Insights and Forecast, 2016-2027
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Drug Class
  1. Anti-inflammatory Biologics
  2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
  3. Corticosteroids
3. Market Analysis, Insights and Forecast – By Application
  1. Autoimmune Inflammatory Diseases
    1. Rheumatoid Arthritis
    2. Psoriasis
    3. Others
  2. Respiratory Diseases
  3. Others
4. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Injection
  3. Inhalation
  4. Topical
5. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacy
  2. Retail Pharmacy
  3. Online Pharmacy
6. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Anti-inflammatory Drugs Market Analysis, Insights and Forecast, 2016-2027
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Drug Class
  1. Anti-inflammatory Biologics
  2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
  3. Corticosteroids
3. Market Analysis, Insights and Forecast – By Application
  1. Autoimmune Inflammatory Diseases
    1. Rheumatoid Arthritis
    2. Psoriasis
    3. Others
  2. Respiratory Diseases
  3. Others
4. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Injection
  3. Inhalation
  4. Topical
5. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacy
  2. Retail Pharmacy
  3. Online Pharmacy
6. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Anti-inflammatory Drugs Market Analysis, Insights and Forecast, 2016-2027
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Drug Class
  1. Anti-inflammatory Biologics
  2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
  3. Corticosteroids
3. Market Analysis, Insights and Forecast – By Application
  1. Autoimmune Inflammatory Diseases
    1. Rheumatoid Arthritis
    2. Psoriasis
    3. Others
  2. Respiratory Diseases
  3. Others
4. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Injection
  3. Inhalation
  4. Topical
5. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacy
  2. Retail Pharmacy
  3. Online Pharmacy
6. Market Analysis, Insights and Forecast – By Countries/ Sub-region
  1. U.K.
  2. Germany
  3. France
  4. Spain
  5. Italy
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Anti-inflammatory Drugs Market Analysis, Insights and Forecast, 2016-2027
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Drug Class
  1. Anti-inflammatory Biologics
  2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
  3. Corticosteroids
3. Market Analysis, Insights and Forecast – By Application
  1. Autoimmune Inflammatory Diseases
    1. Rheumatoid Arthritis
    2. Psoriasis
    3. Others
  2. Respiratory Diseases
  3. Others
4. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Injection
  3. Inhalation
  4. Topical
5. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacy
  2. Retail Pharmacy
  3. Online Pharmacy
6. Market Analysis, Insights and Forecast – By Countries/ Sub-region
  1. Japan
  2. China
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Anti-inflammatory Drugs Market Analysis, Insights and Forecast, 2016-2027
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Drug Class
  1. Anti-inflammatory Biologics
  2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
  3. Corticosteroids
3. Market Analysis, Insights and Forecast – By Application
  1. Autoimmune Inflammatory Diseases
    1. Rheumatoid Arthritis
    2. Psoriasis
    3. Others
  2. Respiratory Diseases
  3. Others
4. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Injection
  3. Inhalation
  4. Topical
5. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacy
  2. Retail Pharmacy
  3. Online Pharmacy
6. Market Analysis, Insights and Forecast – By Countries/ Sub regions
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Anti-inflammatory Drugs Market Analysis, Insights and Forecast, 2016-2027
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Drug Class
  1. Anti-inflammatory Biologics
  2. Non-steroidal Anti-inflammatory Drugs (NSAIDs)
  3. Corticosteroids
3. Market Analysis, Insights and Forecast – By Application
  1. Autoimmune Inflammatory Diseases
    1. Rheumatoid Arthritis
    2. Psoriasis
    3. Others
  2. Respiratory Diseases
  3. Others
4. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Injection
  3. Inhalation
  4. Topical
5. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacy
  2. Retail Pharmacy
  3. Online Pharmacy
6. Market Analysis, Insights and Forecast – By Countries/ Sub region
  1. South Africa
  2. GCC
  3. Rest of Middle East & Africa
Competitive Analysis
1. Key Industry Developments
2. Global Market Share Analysis (2019)
3. Company Profiles (Overview, Product & Services, SWOT analysis, Recent developments, strategies, financials (based on availability))
  1. AbbVie Inc.
    1. Overview,
    2. Product & Services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  2. Johnson & Johnson Services, Inc.
    1. Overview,
    2. Product & Services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  3. Bristol-Myers Squibb Company
    1. Overview,
    2. Product & Services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  4. Merck & Co., Inc.
    1. Overview,
    2. Product & Services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  5. Pfizer Inc.
    1. Overview,
    2. Product & Services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  6. Novartis AG
    1. Overview,
    2. Product & Services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  7. GlaxoSmithKline plc.
    1. Overview,
    2. Product & Services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  8. Eli Lilly and Company
    1. Overview,
    2. Product & Services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  9. Amgen Inc.
    1. Overview,
    2. Product & Services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  10. Biogen
    1. Overview,
    2. Product & Services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  11. Other Prominent Players
    1. Overview,
    2. Product & Services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
Strategic Recommendations

Read Less

List of Figures

Figure 1: Global Anti-inflammatory Drugs Market Revenue Breakdown (US$ Bn, %) by Region, 2019 & 2027

Figure 2: Global Anti-inflammatory Drugs Market Value Share (%), by Drug Class, 2019 & 2027

Figure 3: Global Anti-inflammatory Drugs Market Forecast (US$ Bn), by Anti-inflammatory Biologics, 2016-2027

Figure 4: Global Anti-inflammatory Drugs Market Forecast (US$ Bn), by Non-steroidal Anti-inflammatory drugs (NSAIDs), 2016-2027

Figure 5: Global Anti-inflammatory Drugs Market Forecast (US$ Bn), by Corticosteroids, 2016-2027

Figure 6: Global Anti-inflammatory Drugs Market Value Share (%), by Application, 2019 & 2027

Figure 7: Global Anti-inflammatory Drugs Market Forecast (US$ Bn), by Autoimmune Inflammatory Diseases, 2016-2027

Figure 8: Global Anti-inflammatory Drugs Market Forecast (US$ Bn), by Respiratory Diseases, 2016-2027

Figure 9: Global Anti-inflammatory Drugs Market Forecast (US$ Bn), by Others, 2016-2027

Figure 10: Global Anti-inflammatory Drugs Market Value Share (%), by Route of Administration, 2019 & 2027

Figure 11: Global Anti-inflammatory Drugs Market Forecast (US$ Bn), by Oral, 2016-2027

Figure 12: Global Anti-inflammatory Drugs Market Forecast (US$ Bn), by Injection, 2016-2027

Figure 13: Global Anti-inflammatory Drugs Market Forecast (US$ Bn), by Inhalation, 2016-2027

Figure 14: Global Anti-inflammatory Drugs Market Forecast (US$ Bn), by Topical, 2016-2027

Figure 15: Global Anti-inflammatory Drugs Market Value Share (%), by Distribution Channel, 2019 & 2027

Figure 16: Global Anti-inflammatory Drugs Market Forecast (US$ Bn), by Hospital Pharmacy, 2016-2027

Figure 17: Global Anti-inflammatory Drugs Market Forecast (US$ Bn), by Retail Pharmacy, 2016-2027

Figure 18: Global Anti-inflammatory Drugs Market Forecast (US$ Bn), by Online Pharmacy, 2016-2027

Figure 19: Global Anti-inflammatory Drugs Market Value (US$ Bn), by Region, 2019 & 2027

Figure 20: North America Anti-inflammatory Drugs Market Value (US$ Bn), by Drug Class, 2019 & 2027

Figure 21: North America Anti-inflammatory Drugs Market Value Share (%), by Drug Class, 2019

Figure 22: North America Anti-inflammatory Drugs Market Value (US$ Bn), by Application, 2019 & 2027

Figure 23: North America Anti-inflammatory Drugs Market Value Share (%), by Application, 2019

Figure 24: North America Anti-inflammatory Drugs Market Value (US$ Bn), by Route of Administration, 2019 & 2027

Figure 25: North America Anti-inflammatory Drugs Market Value Share (%), by Route of Administration, 2019

Figure 26: North America Anti-inflammatory Drugs Market Value (US$ Bn), by Distribution Channel, 2019 & 2027

Figure 27: North America Anti-inflammatory Drugs Market Value Share (%), by Distribution Channel, 2019

Figure 28: North America Anti-inflammatory Drugs Market Value (US$ Bn), By Country, 2019 & 2027

Figure 29: North America Anti-inflammatory Drugs Market Value Share (%), By Country, 2019

Figure 30: Europe Anti-inflammatory Drugs Market Value (US$ Bn), by Drug Class, 2019 & 2027

Figure 31: Europe Anti-inflammatory Drugs Market Value Share (%), by Drug Class, 2019

Figure 32: Europe Anti-inflammatory Drugs Market Value (US$ Bn), by Application, 2019 & 2027

Figure 33: Europe Anti-inflammatory Drugs Market Value Share (%), by Application, 2019

Figure 34: Europe Anti-inflammatory Drugs Market Value (US$ Bn), by Route of Administration, 2019 & 2027

Figure 35: Europe Anti-inflammatory Drugs Market Value Share (%), by Route of Administration, 2019

Figure 36: Europe Anti-inflammatory Drugs Market Value (US$ Bn), by Distribution Channel, 2019 & 2027

Figure 37: Europe Anti-inflammatory Drugs Market Value Share (%), by Distribution Channel, 2019

Figure 38: Europe Anti-inflammatory Drugs Market Value (US$ Bn), By Country/ Sub-region, 2019 & 2027

Figure 39: Europe Anti-inflammatory Drugs Market Value Share (%), By Country/ Sub-region, 2019

Figure 40: Asia Pacific Anti-inflammatory Drugs Market Value (US$ Bn), by Drug Class, 2019 & 2027

Figure 41: Asia Pacific Anti-inflammatory Drugs Market Value Share (%), by Drug Class, 2019

Figure 42: Asia Pacific Anti-inflammatory Drugs Market Value (US$ Bn), by Application, 2019 & 2027

Figure 43: Asia Pacific Anti-inflammatory Drugs Market Value Share (%), by Application, 2019

Figure 44: Asia Pacific Anti-inflammatory Drugs Market Value (US$ Bn), by Route of Administration, 2019 & 2027

Figure 45: Asia Pacific Anti-inflammatory Drugs Market Value Share (%), by Route of Administration, 2019

Figure 46: Asia Pacific Anti-inflammatory Drugs Market Value (US$ Bn), by Distribution Channel, 2019 & 2027

Figure 47: Asia Pacific Anti-inflammatory Drugs Market Value Share (%), by Distribution Channel, 2019

Figure 48: Asia Pacific Anti-inflammatory Drugs Market Value (US$ Bn), By Country/ Sub-region, 2019 & 2027

Figure 49: Asia Pacific Anti-inflammatory Drugs Market Value Share (%), By Country/ Sub-region, 2019

Figure 50: Latin America Anti-inflammatory Drugs Market Value (US$ Bn), by Drug Class, 2019 & 2027

Figure 51: Latin America Anti-inflammatory Drugs Market Value Share (%), by Drug Class, 2019

Figure 52: Latin America Anti-inflammatory Drugs Market Value (US$ Bn), by Application, 2019 & 2027

Figure 53: Latin America Anti-inflammatory Drugs Market Value Share (%), by Application, 2019

Figure 54: Latin America Anti-inflammatory Drugs Market Value (US$ Bn), by Route of Administration, 2019 & 2027

Figure 55: Latin America Anti-inflammatory Drugs Market Value Share (%), by Route of Administration, 2019

Figure 56: Latin America Anti-inflammatory Drugs Market Value (US$ Bn), by Distribution Channel, 2019 & 2027

Figure 57: Latin America Anti-inflammatory Drugs Market Value Share (%), by Distribution Channel, 2019

Figure 58: Latin America Anti-inflammatory Drugs Market Value (US$ Bn), By Country/ Sub-region, 2019 & 2027

Figure 59: Latin America Anti-inflammatory Drugs Market Value Share (%), By Country/ Sub-region, 2019

Figure 60: Middle East & Africa Anti-inflammatory Drugs Market Value (US$ Bn), by Drug Class, 2019 & 2027

Figure 61: Middle East & Africa Anti-inflammatory Drugs Market Value Share (%), by Drug Class, 2019

Figure 62: Middle East & Africa Anti-inflammatory Drugs Market Value (US$ Bn), by Application, 2019 & 2027

Figure 63: Middle East & Africa Anti-inflammatory Drugs Market Value Share (%), by Application, 2019

Figure 64: Middle East & Africa Anti-inflammatory Drugs Market Value (US$ Bn), by Route of Administration, 2019 & 2027

Figure 65: Middle East & Africa Anti-inflammatory Drugs Market Value Share (%), by Route of Administration, 2019

Figure 66: Middle East & Africa Anti-inflammatory Drugs Market Value (US$ Bn), by Distribution Channel, 2019 & 2027

Figure 67: Middle East & Africa Anti-inflammatory Drugs Market Value Share (%), by Distribution Channel, 2019

Figure 68: Middle East & Africa Anti-inflammatory Drugs Market Value (US$ Bn), By Country/ Sub-region, 2019 & 2027

Figure 69: Middle East & Africa Anti-inflammatory Drugs Market Value Share (%), By Country/ Sub-region, 2019

Figure 70: Global Anti-inflammatory Drugs Market Share (%), By Company, 2019

List of Tables

Table 1: Global Anti-inflammatory Drugs Market Revenue (US$ Bn) Forecast, by Drug Class, 2016–2027

Table 2: Global Anti-inflammatory Drugs Market Revenue (US$ Bn) Forecast, by Application, 2016–2027

Table 3: Global Anti-inflammatory Drugs Market Revenue (US$ Bn) Forecast, by Autoimmune Inflammatory Diseases, 2016–2027

Table 4: Global Anti-inflammatory Drugs Market Revenue (US$ Bn) Forecast, by Route of Administration, 2016–2027

Table 5: Global Anti-inflammatory Drugs Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016–2027

Table 6: Global Anti-inflammatory Drugs Market Revenue (US$ Bn) Forecast, by Region, 2016-2027

Table 7: North America Anti-inflammatory Drugs Market Revenue (US$ Bn) Forecast, by Drug Class, 2016-2027

Table 8: North America Anti-inflammatory Drugs Market Revenue (US$ Bn) Forecast, by Application, 2016-2027

Table 9: North America Anti-inflammatory Drugs Market Revenue (US$ Bn) Forecast, by Autoimmune Inflammatory Diseases, 2016–2027

Table 10: North America Anti-inflammatory Drugs Market Revenue (US$ Bn) Forecast, by Route of Administration, 2016-2027

Table 11: North America Anti-inflammatory Drugs Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027

Table 12: North America Anti-inflammatory Drugs Market Revenue (US$ Bn) Forecast, By Country, 2016-2027

Table 13: Europe Anti-inflammatory Drugs Market Revenue (US$ Bn) Forecast, by Drug Class, 2016-2027

Table 14: Europe Anti-inflammatory Drugs Market Revenue (US$ Bn) Forecast, by Application, 2016-2027

Table 15: Europe Anti-inflammatory Drugs Market Revenue (US$ Bn) Forecast, by Autoimmune Inflammatory Diseases, 2016–2027

Table 16: Europe Anti-inflammatory Drugs Market Revenue (US$ Bn) Forecast, by Route of Administration, 2016-2027

Table 17: Europe Anti-inflammatory Drugs Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027

Table 18: Europe Anti-inflammatory Drugs Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2016-2027

Table 19: Asia Pacific Anti-inflammatory Drugs Market Revenue (US$ Bn) Forecast, by Drug Class, 2016-2027

Table 20: Asia Pacific Anti-inflammatory Drugs Market Revenue (US$ Bn) Forecast, by Application, 2016-2027

Table 21: Asia Pacific Anti-inflammatory Drugs Market Revenue (US$ Bn) Forecast, by Autoimmune Inflammatory Diseases, 2016–2027

Table 22: Asia Pacific Anti-inflammatory Drugs Market Revenue (US$ Bn) Forecast, by Route of Administration, 2016-2027

Table 23: Asia Pacific Anti-inflammatory Drugs Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027

Table 24: Asia Pacific Anti-inflammatory Drugs Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2016-2027

Table 25: Latin America Anti-inflammatory Drugs Market Revenue (US$ Bn) Forecast, by Drug Class, 2016-2027

Table 26: Latin America Anti-inflammatory Drugs Market Revenue (US$ Bn) Forecast, by Application, 2016-2027

Table 27: Latin America Anti-inflammatory Drugs Market Revenue (US$ Bn) Forecast, by Autoimmune Inflammatory Diseases, 2016–2027

Table 28: Latin America Anti-inflammatory Drugs Market Revenue (US$ Bn) Forecast, by Route of Administration, 2016-2027

Table 29: Latin America Anti-inflammatory Drugs Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027

Table 30: Latin America Anti-inflammatory Drugs Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2016-2027

Table 31: Middle East & Africa Anti-inflammatory Drugs Market Revenue (US$ Bn) Forecast, by Drug Class, 2016-2027

Table 32: Middle East & Africa Anti-inflammatory Drugs Market Revenue (US$ Bn) Forecast, by Application, 2016-2027

Table 33: Middle East & Africa Anti-inflammatory Drugs Market Revenue (US$ Bn) Forecast, by Autoimmune Inflammatory Diseases, 2016–2027

Table 34: Middle East & Africa Anti-inflammatory Drugs Market Revenue (US$ Bn) Forecast, by Route of Administration, 2016-2027

Table 35: Middle East & Africa Anti-inflammatory Drugs Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027

Table 36: Middle East & Africa Anti-inflammatory Drugs Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2016-2027

REPORT UPDATE
IN PROCESS
STUDY PERIOD: 2019-2032
(In Process)
BASE YEAR:2023
(In Process)

Consulting Services

Healthcare Clients

Related Reports

Get in Touch with Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
[email protected]